rebiotix 产品代理
rebiotix 产品代理
该公司正站在捷运这一令人兴奋的潜在医学突破的前沿™ 毒品平台。MRT药物平台用于开发由活微生物组成的制剂，通过我们的临床项目评估该制剂应对挑战性疾病的能力。
Rebiotix希望通过在监管机构的支持下开发和测试的标准化和稳定的试验药物，实现恢复肠道微生物群的承诺
Our Therapy
The Human Microbiome
Microbiota Restoration Therapy
Clostridium difficile Infection
The Future of Microbiome-Based Therapeutics
Clinical Trials
RBX2660 Clinical Trials
RBX7455 Clinical Evaluation
Rebiotix Inc., a Ferring Company, is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating diseases by harnessing the power of the human microbiome.
The company is on the forefront of an exciting potential medical breakthrough with our MRT™ drug platform. The MRT drug platform is leveraged to develop formulations consisting of live microbes, which are evaluated through our clinical program for the formulation’s ability to address challenging diseases.
Rebiotix looks to deliver on the promise of restoring the gut microbiota via standardized and stabilized investigational drugs that have been developed and tested under the auspices of a regulatory authority.
